What can immunology contribute to the control of the world's leading cause of death from bacterial infection?

Immunological Reviews

Volumn 264, Issue 1, 2015, Pages 2-5

  Nathan, Carl ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CAUSE OF DEATH; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; INFECTION CONTROL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS; BACTERIAL INFECTIONS;

BACTERIAL INFECTIONS; CAUSE OF DEATH; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84923206660     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12277     Document Type: Article

References (31)

1. Nathan C. Antibiotics at the crossroads. Nature 2004;431:899-902.
2. Nathan C. Fresh approaches to anti-infective therapies. Sci Transl Med 2012;4:140sr142.
3. Nathan C, Cars O. Antibiotic resistance-problems, progress, prospects. New Engl J Med 2014;371:1761-1763.
4. Nathan C. Aligning pharmaceutical innovation with medical need. Nat Med 2007;13:304-308.
5. Nathan C. Taming tuberculosis: a challenge for science and society. Cell Host Microbe 2009;5:220-224.
6. Flynn JL, Gideon HP, Mattila JT, Ling Lin P. Immunology studies in non-human primate models of tuberculosis. Immunol Rev 2015;264:60-73.
7. Cliff JM, Kaufmann SHE, McShane H, van Helden P, O'Garra A. The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev 2015;264:88-102.
8. Majlessi L, Prados-Rosales R, Casadevall A, Brosch R. Release of mycobacterial antigens. Immunol Rev 2015;264:25-45.
9. Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 2015;264:74-87.
10. Van Rhijn I, Moody DB. CD1 and mycobacterial lipids activate human T cells. Immunol Rev 2015;264:138-153.
11. Gold MC, Napier RJ, Lewinsohn DM. MR1-resctricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobactrerium tuberculosis. Immunol Rev 2015;264:154-166.
12. Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunol Rev 2015;264:167-181.
13. Stamm CE, Collins AC, Shiloh MU. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus. Immunol Rev 2015;264:204-219.
14. Hmama Z, Pena-Diaz S, Joseph S, Av-Gay Y. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis. Immunol Rev 2015;264:220-232.
15. Boisson-Dupuis S, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev 2015;264:103-120.
16. Ronacher K, Joosten SA, van Crevel R, Dockrell HM, Walzl G, Ottenhoff THM. Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunol Rev 2015;264:121-137.
17. Brites D, Gagneux S. Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol Rev 2015;264:6-24.
18. Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev 2015;264:182-203.
19. Neyrolles O, Wolschendorf F, Mitra A, Niederweis M. Mycobacteria, metals, and macrophages. Immunol Rev 2015;264:249-263.
20. Tan S, Russel DG. Trans-species communication in the Mycobacterium tuberculosis-infected macrophage. Immunol Rev 2015;264:233-248.
21. Ehrt S, Rhee K, Schnappinger D. Mycobacterial genes essential for the pathogen's survival in the host. Immunol Rev 2015;264:319-326.
22. Hawn TR, Shah JA, Kalman D. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev 2015;264:344-362.
23. Nathan C, Barry CE III. TB drug development: immunology at the table. Immunol Rev 2015;264:308-318.
24. Comas I, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010;42:498-503.
25. Matty MA, Roca FJ, Cronan MR, Tobin DM. Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma. Immun Rev 2015;264:276-287.
26. Robinson RT, Orme IM, Cooper AM. The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression. Immunol Rev 2015;264:46-59.
27. Lenaerts A, Barry CE III, Dartois V. Heterogeneity in tuberculosis pathology, microenvironments, and therapeutic responses. Immunol Rev 2015;264:288-307.
28. Blaser MJ, Kirschner D. The equilibria that allow bacterial persistence in human hosts. Nature 2007;449:843-849.
29. Karp CL, Wilson CB, Stuart LM. Tuberculosis vaccines: barrier and prospets on the quest for a transformative tool. Immunol Rev 2015;264:363-381.
30. Mayer-Barber KD, Sher A. Cytokine and lipid mediator networks in tuberculosis. Immunol Rev 2015;264:264-275.
31. Baer CE, Rubin EJ, Sassetti CM. New insights into TB physiology suggest untapped therapeutic opportunities. Immunol Rev 2015;264:327-343.